Deaminet 2026: Breakthroughs in Base Editing, Deaminase Biology, and Therapeutic Translation
Type
Blog Post
... nearly half of all pathogenic SNVs, faithful detection of ABE off-targets remains challenging. Siyuan.../CTA filing for PM577a is on track for the first half of 2026.
4. RNA editing comes into its own
RNA editing...APOBEC3B tumors as potential targets for synthetic lethal therapeutic strategies.
Sarat Chandarlapaty (MSKCC...